Joseph Luminiello

Chief Executive Officer at Third Coast Therapeutics, Inc.

Health Technology

Commercial Services

Profile

Joseph Luminiello currently works at Ave Maria Biotechnology LLC, as Chief Executive Officer from 2021 and Third Coast Therapeutics, Inc., as Chief Executive Officer.

Joseph Luminiello active positions

Companies	Position	Start
Third Coast Therapeutics, Inc. Third Coast Therapeutics, Inc. Medical SpecialtiesHealth Technology Third Coast Therapeutics, Inc. engages in pharmaceutical industry. It offers cancer treatment by developing orally active and small molecule drugs. The company is headquartered in Evanston, IL.	Chief Executive Officer	-
Ave Maria Biotechnology LLC Ave Maria Biotechnology LLC Miscellaneous Commercial ServicesCommercial Services Ave Maria Biotechnology LLC provides healthcare services focusing on cell-based therapies. The firm's patented technology utilizes re-programmed adult cells for generic or patient-specific fully human biologic drug manufacturing. The company was founded by Thesesa A. Deisher in 2008 and is headquartered in Seattle, WA.	Chief Executive Officer	01/08/2021

All active positions of Joseph Luminiello

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Joseph Luminiello's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Third Coast Therapeutics, Inc. Third Coast Therapeutics, Inc. Medical SpecialtiesHealth Technology Third Coast Therapeutics, Inc. engages in pharmaceutical industry. It offers cancer treatment by developing orally active and small molecule drugs. The company is headquartered in Evanston, IL.	Health Technology
Ave Maria Biotechnology LLC Ave Maria Biotechnology LLC Miscellaneous Commercial ServicesCommercial Services Ave Maria Biotechnology LLC provides healthcare services focusing on cell-based therapies. The firm's patented technology utilizes re-programmed adult cells for generic or patient-specific fully human biologic drug manufacturing. The company was founded by Thesesa A. Deisher in 2008 and is headquartered in Seattle, WA.	Commercial Services